Palvella Therapeutics PVLA Net Income

Net Income at other companies

Relay Therapeutics, Inc.RLAY

-$83.71M-18.9%

Viridian Therapeutics, Inc.VRDN

-$127.12M-26.2%

ANI PharmaceuticalsANIP

$24.71M+189%

Arcutis Biotherapeutics, Inc.ARQT

$15.01M+194%

Zevra Therapeutics, Inc.ZVRA

$8.75M-88.3%

Eton Pharmaceuticals, Inc.ETON

$1.55M+199%

FAQ

What is Palvella Therapeutics's net income?

Palvella Therapeutics (PVLA) reported net income of -$15.77M in Q1 2026.

How has Palvella Therapeutics's net income changed year-over-year?

Palvella Therapeutics's net income decreased by 92.6% year-over-year, from -$8.19M to -$15.77M.

What is the long-term trend for Palvella Therapeutics's net income?

Over 4 years (2021 to 2025), Palvella Therapeutics's net income has grown at a -2.3% compound annual growth rate (CAGR), from -$45.74M to -$41.72M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.